drugset / Trial / NCT00247390

Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.

NCT00247390

Phase 3 Completed 451 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study to determine the long-term efficacy and safety of ramelteon, once daily (QD).

Timeline

Start
2005-07
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown 8 mg Oral

Indications